4 years ago

A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor

A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor
Christoph Bock, Sara Sdelci, Thomas Penz, André C Müller, Patrick Markt, Rebecca Herzog, Vladimir Ivanov, Michael Caldera, Michael Schuster, Anna Ringler, Stefan Kubicek, Bernd Boidol, Keiryn L Bennett, Gerhard Dürnberger, Jörg Menche, Anja Wagner, Charles-Hugues Lardeau, Marco P Licciardello, Jacques Colinge, Yasin Folkvaljon, Erika Schirghuber, Klaus Kratochwill, Pär Stattin, Freya Klepsch
Approved drugs are invaluable tools to study biochemical pathways, and further characterization of these compounds may lead to repurposing of single drugs or combinations. Here we describe a collection of 308 small molecules representing the diversity of structures and molecular targets of all FDA-approved chemical entities. The CeMM Library of Unique Drugs (CLOUD) covers prodrugs and active forms at pharmacologically relevant concentrations and is ideally suited for combinatorial studies. We screened pairwise combinations of CLOUD drugs for impairment of cancer cell viability and discovered a synergistic interaction between flutamide and phenprocoumon (PPC). The combination of these drugs modulates the stability of the androgen receptor (AR) and resensitizes AR-mutant prostate cancer cells to flutamide. Mechanistically, we show that the AR is a substrate for γ-carboxylation, a post-translational modification inhibited by PPC. Collectively, our data suggest that PPC could be repurposed to tackle resistance to antiandrogens in prostate cancer patients.

Publisher URL: http://dx.doi.org/10.1038/nchembio.2382

DOI: 10.1038/nchembio.2382

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.